Compare Dolby Laboratories, Inc. (DLB) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Quantumscape Corp — how do they compare? Dolby Laboratories, Inc. trades at $58.63 (market cap $5.47B), while Quantumscape Corp trades at $4.58 (market cap $2.82B). The key difference: Dolby Laboratories, Inc. is the larger of the two by market cap, and Dolby Laboratories, Inc. pays a 2.46% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Quantumscape Corp for 37 Days on average.
| DLB | QS | |
|---|---|---|
Market Cap | $5.47B | $2.82B |
Volume | 1,058,284 | 21,878,246 |
Sector | Technology | Consumer Cyclical |
52-Week High | $70.09 | $18.44 |
52-Week Low | $48.51 | $4.52 |
Typical Hold Time | 98 Days | 37 Days |
Enterprise Value | $4.85B | $2.03B |
Dividend Yield | 2.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.67, up 0.55% with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with 87.61% gross margins and 16.7% net income margins, though revenue has remained flat around $1.3B. Recent developments include expanded partnerships with Meta and leadership transition to new CEO Marc Whitten.
DLB offers value with analyst consensus target of $90.33 (54% upside) but faces near-term execution risks and licensing volatility. The stock trades at reasonable valuations (P/E 24.87, P/S 4.15) with solid cash flow generation, though technical indicators suggest caution amid bearish momentum signals.
QuantumScape (QS) trades at $4.58, up 1.33% with bearish technical signals and negative profitability metrics. The company remains pre-revenue with significant cash burn, though recent earnings beat expectations. Analyst consensus shows 72.7% hold ratings with a $10.35 price target, while insider selling and delayed commercialization timelines create headwinds.
QS faces substantial execution risk with commercialization not expected until 2029, but maintains automotive partnerships and pilot production progress. The stock trades near 52-week lows, offering potential upside to analyst targets if technology milestones are achieved, though high cash burn and competitive threats remain key concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
